Skip to main content
CLGN logo

CLGN · CollPlant Biotechnologies Ltd

$0.31 -0.02 (-4.82%) At close · Jul 29
Market Cap
$5.90M
Shares
18.91M

CollPlant Biotechnologies Ltd Earnings Call Transcripts

Every quarterly earnings call for CollPlant Biotechnologies Ltd (CLGN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
Earnings call
FY24 · Q3
2024-09-30
CollPlant Biotechnologies Ltd Q3 FY2024 Earnings Call
Positive tone Regenerative breast implant preclinical study Business development and partnerships rhCollagen platform / technology
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
CollPlant Biotechnologies Ltd Q2 FY2024 Earnings Call
Confident tone AbbVie dermal filler partnership Regenerative breast implant program rhCollagen and bioink platform
Revenue
$249,000
▼ 97.6% YoY
Diluted EPS
$0.37
▼ 24.5% YoY
Gross margin
-115.3%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
CollPlant Biotechnologies Ltd Q1 FY2024 Earnings Call
Positive tone AbbVie Dermal Filler Partnership Regenerative Breast Implants FDA Regulatory Pathway
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
CollPlant Biotechnologies Ltd Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
CollPlant Biotechnologies Ltd Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
CollPlant Biotechnologies Ltd Q2 FY2023 Earnings Call
Revenue
$10.18M
▲ 15330.3% YoY
Diluted EPS
$0.49
Gross margin
94.0%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
CollPlant Biotechnologies Ltd Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
CollPlant Biotechnologies Ltd Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–8 of 8 earnings calls
Key facts CIK 1631487 CUSIP M2R51X116 13F (30d) 2 filings 2 filers Visit website Investor relations